Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG Multicentre Trial

Michael Douek (Corresponding Author), Joost Klaase, Ian Monypenny, Ashutosh Kothari, Katalin Zechmeister, Douglas Brown, Lynda Wyld, Philip Drew, Hans Garmo, Olorunsola Agbaje, Quentin Pankhurst, Bauke Anninga, Maarten Grootendorst, Bennie Ten Haken, Margaret A Hall-Craggs, Arnie Purushotham, Sarah Pinder, SentiMAG Trialists Group

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

BACKGROUND: The SentiMAG Multicentre Trial evaluated a new magnetic technique for sentinel lymph node biopsy (SLNB) against the standard (radioisotope and blue dye or radioisotope alone). The magnetic technique does not use radiation and provides both a color change (brown dye) and a handheld probe for node localization. The primary end point of this trial was defined as the proportion of sentinel nodes detected with each technique (identification rate).

METHODS: A total of 160 women with breast cancer scheduled for SLNB, who were clinically and radiologically node negative, were recruited from seven centers in the United Kingdom and The Netherlands. SLNB was undertaken after administration of both the magnetic and standard tracers (radioisotope with or without blue dye).

RESULTS: A total of 170 SLNB procedures were undertaken on 161 patients, and 1 patient was excluded, leaving 160 patients for further analysis. The identification rate was 95.0 % (152 of 160) with the standard technique and 94.4 % (151 of 160) with the magnetic technique (0.6 % difference; 95 % upper confidence limit 4.4 %; 6.9 % discordance). Of the 22 % (35 of 160) of patients with lymph node involvement, 16 % (25 of 160) had at least 1 macrometastasis, and 6 % (10 of 160) had at least a micrometastasis. Another 2.5 % (4 of 160) had isolated tumor cells. Of 404 lymph nodes removed, 297 (74 %) were true sentinel nodes. The lymph node retrieval rate was 2.5 nodes per patient overall, 1.9 nodes per patient with the standard technique, and 2.0 nodes per patient with the magnetic technique.

CONCLUSIONS: The magnetic technique is a feasible technique for SLNB, with an identification rate that is not inferior to the standard technique.

Original languageEnglish
Pages (from-to)1237-1245
Number of pages9
JournalAnnals of Surgical Oncology
Volume21
Issue number4
Early online date10 Dec 2013
DOIs
Publication statusPublished - Apr 2014

Fingerprint

Multicenter Studies
Sentinel Lymph Node Biopsy
Biopsy
Radioisotopes
Coloring Agents
Lymph Nodes
Neoplasm Micrometastasis
cyhalothrin
Netherlands
Color
Radiation
Breast Neoplasms
Neoplasms

Cite this

Douek, M., Klaase, J., Monypenny, I., Kothari, A., Zechmeister, K., Brown, D., ... SentiMAG Trialists Group (2014). Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG Multicentre Trial. Annals of Surgical Oncology, 21(4), 1237-1245. https://doi.org/10.1245/s10434-013-3379-6

Sentinel node biopsy using a magnetic tracer versus standard technique : the SentiMAG Multicentre Trial. / Douek, Michael (Corresponding Author); Klaase, Joost; Monypenny, Ian; Kothari, Ashutosh; Zechmeister, Katalin; Brown, Douglas; Wyld, Lynda; Drew, Philip; Garmo, Hans; Agbaje, Olorunsola; Pankhurst, Quentin; Anninga, Bauke; Grootendorst, Maarten; Ten Haken, Bennie; Hall-Craggs, Margaret A; Purushotham, Arnie; Pinder, Sarah; SentiMAG Trialists Group.

In: Annals of Surgical Oncology, Vol. 21, No. 4, 04.2014, p. 1237-1245.

Research output: Contribution to journalArticle

Douek, M, Klaase, J, Monypenny, I, Kothari, A, Zechmeister, K, Brown, D, Wyld, L, Drew, P, Garmo, H, Agbaje, O, Pankhurst, Q, Anninga, B, Grootendorst, M, Ten Haken, B, Hall-Craggs, MA, Purushotham, A, Pinder, S & SentiMAG Trialists Group 2014, 'Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG Multicentre Trial', Annals of Surgical Oncology, vol. 21, no. 4, pp. 1237-1245. https://doi.org/10.1245/s10434-013-3379-6
Douek, Michael ; Klaase, Joost ; Monypenny, Ian ; Kothari, Ashutosh ; Zechmeister, Katalin ; Brown, Douglas ; Wyld, Lynda ; Drew, Philip ; Garmo, Hans ; Agbaje, Olorunsola ; Pankhurst, Quentin ; Anninga, Bauke ; Grootendorst, Maarten ; Ten Haken, Bennie ; Hall-Craggs, Margaret A ; Purushotham, Arnie ; Pinder, Sarah ; SentiMAG Trialists Group. / Sentinel node biopsy using a magnetic tracer versus standard technique : the SentiMAG Multicentre Trial. In: Annals of Surgical Oncology. 2014 ; Vol. 21, No. 4. pp. 1237-1245.
@article{49ed83a303a541a69a5fac61d3e45aa5,
title = "Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG Multicentre Trial",
abstract = "BACKGROUND: The SentiMAG Multicentre Trial evaluated a new magnetic technique for sentinel lymph node biopsy (SLNB) against the standard (radioisotope and blue dye or radioisotope alone). The magnetic technique does not use radiation and provides both a color change (brown dye) and a handheld probe for node localization. The primary end point of this trial was defined as the proportion of sentinel nodes detected with each technique (identification rate).METHODS: A total of 160 women with breast cancer scheduled for SLNB, who were clinically and radiologically node negative, were recruited from seven centers in the United Kingdom and The Netherlands. SLNB was undertaken after administration of both the magnetic and standard tracers (radioisotope with or without blue dye).RESULTS: A total of 170 SLNB procedures were undertaken on 161 patients, and 1 patient was excluded, leaving 160 patients for further analysis. The identification rate was 95.0 {\%} (152 of 160) with the standard technique and 94.4 {\%} (151 of 160) with the magnetic technique (0.6 {\%} difference; 95 {\%} upper confidence limit 4.4 {\%}; 6.9 {\%} discordance). Of the 22 {\%} (35 of 160) of patients with lymph node involvement, 16 {\%} (25 of 160) had at least 1 macrometastasis, and 6 {\%} (10 of 160) had at least a micrometastasis. Another 2.5 {\%} (4 of 160) had isolated tumor cells. Of 404 lymph nodes removed, 297 (74 {\%}) were true sentinel nodes. The lymph node retrieval rate was 2.5 nodes per patient overall, 1.9 nodes per patient with the standard technique, and 2.0 nodes per patient with the magnetic technique.CONCLUSIONS: The magnetic technique is a feasible technique for SLNB, with an identification rate that is not inferior to the standard technique.",
author = "Michael Douek and Joost Klaase and Ian Monypenny and Ashutosh Kothari and Katalin Zechmeister and Douglas Brown and Lynda Wyld and Philip Drew and Hans Garmo and Olorunsola Agbaje and Quentin Pankhurst and Bauke Anninga and Maarten Grootendorst and {Ten Haken}, Bennie and Hall-Craggs, {Margaret A} and Arnie Purushotham and Sarah Pinder and {SentiMAG Trialists Group} and Yazan Masannat",
note = "Acknowledgment The authors thank the patients and their relatives for participating in this trial. They also thank the research nurses and the National Institute of Health Research (NIHR) for helping recruit patients into the trial; the Clinical Research Coordinator (Medische Spectrum Twente, Enschede, The Netherlands) for helping with patient recruitment and data management; members of the Data Monitoring Committee for their valuable advice (Miss Zoe Winters, Dr. Jane Warwick, and Dr. Jurgen F{\"u}tterer); Endomagnetics Ltd. (UK) for providing an educational grant to fund this clinical trial. This work was supported by the Experimental Cancer Medicine Centre Initiative which is jointly funded by Cancer Research UK, the NIHR in England and the Departments of Health for Scotland, Wales and Northern Ireland. The research was also supported by the NIHR Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London. The sponsors of this trial are King’s College London, UK and Guy’s & St Thomas’ Hospitals NHS Foundation Trust. Funding Unrestricted Education Grant from Endomagnetics Ltd., UK. UK National Institute of Health Research (NIHR) adopted trial.",
year = "2014",
month = "4",
doi = "10.1245/s10434-013-3379-6",
language = "English",
volume = "21",
pages = "1237--1245",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Sentinel node biopsy using a magnetic tracer versus standard technique

T2 - the SentiMAG Multicentre Trial

AU - Douek, Michael

AU - Klaase, Joost

AU - Monypenny, Ian

AU - Kothari, Ashutosh

AU - Zechmeister, Katalin

AU - Brown, Douglas

AU - Wyld, Lynda

AU - Drew, Philip

AU - Garmo, Hans

AU - Agbaje, Olorunsola

AU - Pankhurst, Quentin

AU - Anninga, Bauke

AU - Grootendorst, Maarten

AU - Ten Haken, Bennie

AU - Hall-Craggs, Margaret A

AU - Purushotham, Arnie

AU - Pinder, Sarah

AU - SentiMAG Trialists Group

AU - Masannat, Yazan

N1 - Acknowledgment The authors thank the patients and their relatives for participating in this trial. They also thank the research nurses and the National Institute of Health Research (NIHR) for helping recruit patients into the trial; the Clinical Research Coordinator (Medische Spectrum Twente, Enschede, The Netherlands) for helping with patient recruitment and data management; members of the Data Monitoring Committee for their valuable advice (Miss Zoe Winters, Dr. Jane Warwick, and Dr. Jurgen Fütterer); Endomagnetics Ltd. (UK) for providing an educational grant to fund this clinical trial. This work was supported by the Experimental Cancer Medicine Centre Initiative which is jointly funded by Cancer Research UK, the NIHR in England and the Departments of Health for Scotland, Wales and Northern Ireland. The research was also supported by the NIHR Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London. The sponsors of this trial are King’s College London, UK and Guy’s & St Thomas’ Hospitals NHS Foundation Trust. Funding Unrestricted Education Grant from Endomagnetics Ltd., UK. UK National Institute of Health Research (NIHR) adopted trial.

PY - 2014/4

Y1 - 2014/4

N2 - BACKGROUND: The SentiMAG Multicentre Trial evaluated a new magnetic technique for sentinel lymph node biopsy (SLNB) against the standard (radioisotope and blue dye or radioisotope alone). The magnetic technique does not use radiation and provides both a color change (brown dye) and a handheld probe for node localization. The primary end point of this trial was defined as the proportion of sentinel nodes detected with each technique (identification rate).METHODS: A total of 160 women with breast cancer scheduled for SLNB, who were clinically and radiologically node negative, were recruited from seven centers in the United Kingdom and The Netherlands. SLNB was undertaken after administration of both the magnetic and standard tracers (radioisotope with or without blue dye).RESULTS: A total of 170 SLNB procedures were undertaken on 161 patients, and 1 patient was excluded, leaving 160 patients for further analysis. The identification rate was 95.0 % (152 of 160) with the standard technique and 94.4 % (151 of 160) with the magnetic technique (0.6 % difference; 95 % upper confidence limit 4.4 %; 6.9 % discordance). Of the 22 % (35 of 160) of patients with lymph node involvement, 16 % (25 of 160) had at least 1 macrometastasis, and 6 % (10 of 160) had at least a micrometastasis. Another 2.5 % (4 of 160) had isolated tumor cells. Of 404 lymph nodes removed, 297 (74 %) were true sentinel nodes. The lymph node retrieval rate was 2.5 nodes per patient overall, 1.9 nodes per patient with the standard technique, and 2.0 nodes per patient with the magnetic technique.CONCLUSIONS: The magnetic technique is a feasible technique for SLNB, with an identification rate that is not inferior to the standard technique.

AB - BACKGROUND: The SentiMAG Multicentre Trial evaluated a new magnetic technique for sentinel lymph node biopsy (SLNB) against the standard (radioisotope and blue dye or radioisotope alone). The magnetic technique does not use radiation and provides both a color change (brown dye) and a handheld probe for node localization. The primary end point of this trial was defined as the proportion of sentinel nodes detected with each technique (identification rate).METHODS: A total of 160 women with breast cancer scheduled for SLNB, who were clinically and radiologically node negative, were recruited from seven centers in the United Kingdom and The Netherlands. SLNB was undertaken after administration of both the magnetic and standard tracers (radioisotope with or without blue dye).RESULTS: A total of 170 SLNB procedures were undertaken on 161 patients, and 1 patient was excluded, leaving 160 patients for further analysis. The identification rate was 95.0 % (152 of 160) with the standard technique and 94.4 % (151 of 160) with the magnetic technique (0.6 % difference; 95 % upper confidence limit 4.4 %; 6.9 % discordance). Of the 22 % (35 of 160) of patients with lymph node involvement, 16 % (25 of 160) had at least 1 macrometastasis, and 6 % (10 of 160) had at least a micrometastasis. Another 2.5 % (4 of 160) had isolated tumor cells. Of 404 lymph nodes removed, 297 (74 %) were true sentinel nodes. The lymph node retrieval rate was 2.5 nodes per patient overall, 1.9 nodes per patient with the standard technique, and 2.0 nodes per patient with the magnetic technique.CONCLUSIONS: The magnetic technique is a feasible technique for SLNB, with an identification rate that is not inferior to the standard technique.

U2 - 10.1245/s10434-013-3379-6

DO - 10.1245/s10434-013-3379-6

M3 - Article

C2 - 24322530

VL - 21

SP - 1237

EP - 1245

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 4

ER -